X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (34573) 34573
Newspaper Article (8804) 8804
Newsletter (2630) 2630
Book Chapter (927) 927
Web Resource (359) 359
Magazine Article (231) 231
Trade Publication Article (128) 128
Transcript (52) 52
Book / eBook (36) 36
Dissertation (13) 13
Conference Proceeding (9) 9
Publication (6) 6
Book Review (3) 3
Reference (3) 3
Report (2) 2
Government Document (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27163) 27163
science & technology (25594) 25594
life sciences & biomedicine (24486) 24486
lymphomas (22595) 22595
oncology (14682) 14682
male (13785) 13785
female (13162) 13162
hematology (11570) 11570
cancer (10512) 10512
middle aged (9782) 9782
adult (8197) 8197
aged (7973) 7973
chemotherapy (7636) 7636
antineoplastic combined chemotherapy protocols - therapeutic use (6889) 6889
leukemia (6119) 6119
lymphoma (5963) 5963
care and treatment (5891) 5891
treatment outcome (5306) 5306
research (5234) 5234
non-hodgkin's lymphomas (4692) 4692
lymphoma, large b-cell, diffuse - drug therapy (4614) 4614
animals (4594) 4594
prognosis (4586) 4586
patients (4395) 4395
rituximab (4312) 4312
clinical trials (4304) 4304
cancer therapies (4260) 4260
apoptosis (4225) 4225
tumors (3947) 3947
adolescent (3744) 3744
antineoplastic agents - therapeutic use (3628) 3628
drug therapy (3504) 3504
health aspects (3252) 3252
aged, 80 and over (3109) 3109
medical research (3088) 3088
proteins (2974) 2974
child (2969) 2969
hemic and lymphatic diseases (2888) 2888
lymphoma, b-cell - drug therapy (2848) 2848
immunotherapy (2834) 2834
pharmaceutical industry (2789) 2789
cell line, tumor (2748) 2748
analysis (2692) 2692
lymphoma, non-hodgkin - drug therapy (2596) 2596
mice (2594) 2594
medicine & public health (2527) 2527
abridged index medicus (2439) 2439
gene expression (2434) 2434
retrospective studies (2434) 2434
cyclophosphamide - administration & dosage (2427) 2427
vincristine - administration & dosage (2328) 2328
lymphocytes b (2324) 2324
lymphoma, large b-cell, diffuse - pathology (2320) 2320
fda approval (2286) 2286
drug dosages (2282) 2282
lymphocytes (2279) 2279
stem cells (2274) 2274
t cells (2250) 2250
kinases (2195) 2195
antineoplastic combined chemotherapy protocols - administration & dosage (2164) 2164
young adult (2121) 2121
doxorubicin - administration & dosage (2120) 2120
studies (2115) 2115
genetic aspects (2108) 2108
disease-free survival (2102) 2102
risk factors (2101) 2101
medical prognosis (2072) 2072
immunology (2056) 2056
child, preschool (1971) 1971
antineoplastic agents (1964) 1964
antigens (1960) 1960
multiple myeloma (1912) 1912
remission induction (1871) 1871
antibodies, monoclonal - therapeutic use (1854) 1854
antibodies, monoclonal, murine-derived (1847) 1847
antimitotic agents (1834) 1834
medicine (1834) 1834
pediatrics (1821) 1821
prednisone - administration & dosage (1818) 1818
transplantation (1803) 1803
combined modality therapy (1798) 1798
apoptosis - drug effects (1785) 1785
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1721) 1721
follow-up studies (1716) 1716
mutation (1716) 1716
neoplasm staging (1693) 1693
bone marrow (1689) 1689
b-cell lymphoma (1672) 1672
recurrence (1637) 1637
cyclophosphamide - therapeutic use (1620) 1620
diagnosis (1609) 1609
antineoplastic agents - pharmacology (1599) 1599
antineoplastic combined chemotherapy protocols - adverse effects (1593) 1593
lymphoma, b-cell - pathology (1592) 1592
pathology (1562) 1562
survival analysis (1545) 1545
development and progression (1539) 1539
survival rate (1516) 1516
biopsy (1515) 1515
vincristine - therapeutic use (1506) 1506
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (46456) 46456
Japanese (513) 513
German (289) 289
Chinese (241) 241
French (233) 233
Spanish (158) 158
Russian (138) 138
Italian (85) 85
Polish (37) 37
Portuguese (33) 33
Danish (22) 22
Korean (22) 22
Hungarian (21) 21
Dutch (13) 13
Czech (12) 12
Croatian (7) 7
Norwegian (7) 7
Turkish (7) 7
Finnish (5) 5
Hebrew (5) 5
Romanian (5) 5
Serbian (5) 5
Ukrainian (4) 4
Lithuanian (2) 2
Swedish (2) 2
Catalan (1) 1
Galician (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 02/2014, Volume 111, Issue 6, pp. 2349 - 2354
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 09/2016, Volume 126, Issue 9, pp. 3351 - 3362
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2017, Volume 377, Issue 26, pp. 2531 - 2544
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 07/2010, Volume 107, Issue 29, pp. 13075 - 13080
Activation of the B-cell antigen receptor (BCR) signaling pathway contributes to the initiation and maintenance of B-cell malignancies and autoimmune diseases... 
T lymphocytes | Animal models | Disease models | Gels | B lymphocytes | B cell lymphoma | Arthritis | Mice | Autoimmune diseases | Tumors | X-linked agammaglobulinemia | Lymphoma | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Arthritis, Experimental - drug therapy | Pyrazoles - therapeutic use | Humans | Benzofurans - administration & dosage | Benzofurans - pharmacology | Autoantibodies - biosynthesis | Pyrimidines - chemistry | Benzofurans - chemistry | Protein Kinase Inhibitors - chemistry | Pyrazoles - chemistry | Lymphoma, B-Cell - enzymology | Autoimmune Diseases - drug therapy | Disease Models, Animal | Lymphoma, B-Cell - drug therapy | Pyrazoles - pharmacology | B-Lymphocytes - enzymology | Benzofurans - therapeutic use | Autoimmune Diseases - enzymology | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Pyrimidines - pharmacology | Receptors, Antigen, B-Cell - immunology | B-Lymphocytes - drug effects | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Animals | B-Lymphocytes - immunology | Signal Transduction - drug effects | Lymphocyte Activation - drug effects | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Dogs | Protein Kinase Inhibitors - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Cell receptors | Models | Lymphomas | Research | Properties | Index Medicus | Biological Sciences | lymphoma
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2013, Volume 368, Issue 15, pp. 1408 - 1416
A dose-intense infusional chemotherapy program plus rituximab had a high degree of efficacy in patients with primary mediastinal B-cell lymphoma, which is genetically related to Hodgkin's lymphoma... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Filgrastim | Dose-Response Relationship, Drug | Young Adult | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Kaplan-Meier Estimate | Rituximab | Stroke Volume - drug effects | Etoposide - administration & dosage | Recombinant Proteins - administration & dosage | Disease-Free Survival | Vincristine - adverse effects | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Drugs | Dose-response relationship (Biochemistry) | Usage | Cyclophosphamide | Patient outcomes | Dosage and administration | Lymphomas | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Doxorubicin | Medical research | Nuclear magnetic resonance--NMR | Disease | Review boards | Genes | Etoposide | Prednisone | Radiation therapy | Kinases | Vincristine | Patients | Morbidity | Chemotherapy | Lymphocytes B | Remission | Mutation | Hodgkin's disease | B-cell lymphoma | Index Medicus | Abridged Index Medicus
Journal Article
Nature medicine, ISSN 1546-170X, 07/2015, Volume 21, Issue 8, pp. 922 - 926
Journal Article
Journal Article